All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Nonprofit supporting patients with inheritable bleeding disorders.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbyists on this filing 2

JOHANNA GRAY

Previously held: Intern, Senator Barack Obama
LESLIE BRADY

Previously held: Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 6

Centers For Medicare and Medicaid Services (CMS)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Internal Revenue Service (IRS)
SENATE
Treasury, Dept of

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
S 864
HELP Copays Act

Lobbying activity 6

Medicare/Medicaid

H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid

Health Issues

Blood and plasma safety and awareness Bleeding disorders awareness

Insurance

H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)

Budget/Appropriations

Letter to Secretary Kennedy regarding the reductions in force at the Centers for Disease Control and Preventions Division of Blood Disorders and Public Health Genomics Funding for federal hemophilia programs in FY25 House and Senate Labor-HHS Appropriations bills NIH FY25 appropriations

Pharmacy

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program

Medical/Disease Research/Clinical Labs

Hemophilia research, prevention, surveillance and service programs and issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.